Skip to main content
. 2020 Dec 9;27:1–7. doi: 10.1016/j.jot.2020.11.001

Table 1.

Patient descriptive characteristics.

Parameters TTT (n ​= ​42) Control (n ​= ​43) p value
Age (years) 63.5 63.1 0.88
Male sex, n (%) 33 (78.6) 33 (76.8) 0.84
Duration of ulcers (months) 6.4 4.9 0.44
Ulcer area (cm2) 16.2 11.0 0.21
University of Texas wound classification system, n (%)
 2-B 6 (14.3) 9 (20.9) 0.42
 2-C 6 (14.3) 7 (16.7) 0.80
 2-D 12 (28.6) 11 (25.6) 0.76
 3-B 1 (2.4) 2 (4.7) 0.98
 3-C 1 (2.4) 1 (2.3) 0.48
 3-D 16 (38.1) 13 (30.2) 0.44
Site of ulcer, n (%)
 Foot 35 (83.3) 30 (69.8) 0.14
 Leg 7 (16.7) 13 (30.2)
Etiology, n (%)
 Arterial 36 (85.7) 32 (74.4) 0.19
 Venous 4 (9.5) 7 (16.7) 0.55
 Mixed 2 (4.8) 4 (9.3) 0.69
Stroke, n (%) 1 (2.4) 0 (0.0) 0.99
Hypertension, n (%) 16 (38.1) 12 (27.9) 0.32
Coronary heart disease, n (%) 4 (9.5) 4 (9.3) 0.74
Current smoker, n (%) 15 (35.7) 24 (55.8) 0.06
Prior treatment, n (%)
 Debridements 39 (92.9) 40 (93.0) 0.98
Negative-pressure wound therapy 0 (0.0) 0 (0.0)
Revascularization 10 (23.8) 11 (25.6) 0.85
Skin graft or equivalent 2 (4.8) 0 (0.0) 0.46
Local or free flap 1 (2.4) 1 (2.3) 0.48
Current treatment, n (%)
Debridements 42 (100.0) 43 (100.0)
Negative-pressure wound therapy 1 (2.4) 1 (2.3) 0.48
Revascularization 0 (0.0) 39 (90.7) <0.001
Skin graft or equivalent 0 (0.0) 0 (0.0)
Local or free flap 0 (0.0) 1 (2.3) 0.48

Data are presented as the mean ​± ​SD or n (%); TTT ​= ​tibial cortex transverse transport